Expert Testimony Excluded on Link Between Gadolinium MRI Contrast Agents and Health Problems Claimed in Lawsuits
A federal judge has dismissed plaintiff experts who were key to proving that gadolinium deposition can cause a host of health problems.
A federal judge has dismissed plaintiff experts who were key to proving that gadolinium deposition can cause a host of health problems.
A new study finds that older, linear gadolinium contrast agents appear to have a much higher risk of leaving behind high levels of gadolinium in the brain.
A Multihance lawsuit claims the MRI contrast dye gave a Louisiana man a condition known as Gadolinium Deposition Disease.
A MultiHance lawsuit claims the gadolinium-based contrast dye cause severe complications, permanent injuries, and the need for hospitalization.
A gadolinium exposure lawsuit blames Optimark and Multihance side effects for fibrosis of organs, skin and bones.
A gadolinium exposure lawsuit claims that IV injections of various MRI contrast dyes caused severe injury due to an allergic reaction.
Changes in children's brains may make them more susceptible to gadolinium retention after the age of two, according to the findings of a new study.
A gadolinium retention lawsuit says Multihance, Magnevist and Omniscan MRI contrast dyes are defective, resulting in injury from toxic chemicals.
A new study indicates that linear gadolinium contrast dyes leave deposits of the chemical in rat brains for at least a year.
A MRI contrast agent lawsuit claims multiple injections of Omniscan and Multihance resulted in gadolinium deposition disease.